Brief: Ackermans' MRM Health Announces First Patient Dosed With MH002

Ackermans & Van Haaren NV

08/12/2021 16:56

Dec 8 (Reuters) - ACKERMANS & VAN HAAREN NV  ACKB.BR :
    * ANNOUNCES FIRST PATIENT DOSED WITH NEXT GENERATION LIVE
MICROBIOME CONSORTIA THERAPEUTIC MH002 IN PHASE 1B/2A STUDY IN
PATIENTS WITH ULCERATIVE COLITIS

Further company coverage:  ACKB.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 587 696 600;))